OZURDEX intravitréen implant dans applicateur
7680603240015
CH-60324
S01BA01
11.99.0.
Reimbursement limitations:
OZURDEX3
Administration uniquement par un ophtalmologiste qualifié ayant de l’expérience dans les injections intravitréennes.
Pour …
1 / 3
google
Details
- Product number
- 6032401
- CPT
- -
- Packaging group
- 1
- Unit
- Stück
- Composition
- dexamethasonum 0.7 mg, poly(lactidum-co-glycolidum) 50/50 (0.16 - 0.24 dl/g) terminatum cum esteri, poly(lactidum-co-glycolidum) 50/50 (0.16 - 0.24 dl/g), pro praeparatione.
Articles (1)
Ozurdex, intravitreales Implantat in Applikator
intravitreales Implantat in Applikator
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
700.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 1051.45
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/01/2012
Authorization holder
AbbVie AG
6330 Cham
Authorization information
- Swissmedic authorization number
- 60324
- Drug name
- Ozurdex, intravitreales Implantat in Applikator
- Galenic form
- IMPL
- ATC Code
- S01BA01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 10/01/2011
- Authorization expiration date
- 31/12/9999
- IT number
- 11.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- OZURDEX intravitréen implant dans applicateur
- Description (DE)
- OZURDEX intravitreales Implant in Applikator
- Market launch
- 10/01/2011
- Narcotic (BTM)
- No